Literature DB >> 12849294

Is it time to conclude that NMDA antagonists have failed?

Rafael Roesler1, João Quevedo, Nadja Schröder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12849294     DOI： 10.1016/s1474-4422(03)00260-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

Review 2.  NMDA receptors in clinical neurology: excitatory times ahead.

Authors:  Lorraine V Kalia; Suneil K Kalia; Michael W Salter
Journal:  Lancet Neurol       Date:  2008-08       Impact factor: 44.182

3.  Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.

Authors:  Dongxu Zhai; Frankie H F Lee; Cheryl D'Souza; Ping Su; Shouping Zhang; Zhengping Jia; Li Zhang; Albert H C Wong; Fang Liu
Journal:  Ann Clin Transl Neurol       Date:  2015-02-19       Impact factor: 4.511

Review 4.  Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions.

Authors:  Abbas Jarrahi; Molly Braun; Meenakshi Ahluwalia; Rohan V Gupta; Michael Wilson; Stephanie Munie; Pankaj Ahluwalia; John R Vender; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Biomedicines       Date:  2020-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.